Hydroxychloroquine Questions

Axios Re:Cap - A podcast by Axios

Hydroxychloroquine has evolved from a sleepy anti-malaria drug into a partisan litmus test over the future of COVID-19 treatment. Dan and Axios healthcare reporter Bob Herman dig into what we know about the drug, what we still don't, and why both matter. PLUS: New money for small businesses and a way to help New York medical workers